Galit Alter
#116,130
Most Influential Person Now
Researcher
Galit Alter's AcademicInfluence.com Rankings
Galit Alterbiology Degrees
Biology
#6744
World Rank
#9528
Historical Rank
Virology
#142
World Rank
#147
Historical Rank
Immunology
#351
World Rank
#365
Historical Rank
Download Badge
Biology
Why Is Galit Alter Influential?
(Suggest an Edit or Addition)According to Wikipedia, Galit Alter is an immunologist and virologist, professor of medicine at Harvard Medical School, and group leader at the Ragon Institute of MGH, MIT and Harvard. She is known for her work on the expansion of particular natural killer cell subtypes in response to HIV-1 infection. She has also contributed to the understanding of how SARS-CoV-2 antibody titers correlate with sustained humoral protection, including identifying coordinated immune cell-antibody signatures that may predict COVID-19 infection outcome.
Galit Alter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CD107a as a functional marker for the identification of natural killer cell activity. (2004) (1271)
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques (2020) (931)
- Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques (2020) (812)
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host (2020) (784)
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques (2020) (779)
- Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques (2020) (736)
- SARS-CoV-2 viral load is associated with increased disease severity and mortality (2020) (576)
- Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 (2009) (526)
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 (2020) (507)
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients (2020) (496)
- Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes (2007) (464)
- Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys (2016) (445)
- Beyond binding: antibody effector functions in infectious diseases (2017) (424)
- Expansion of HIV-specific T follicular helper cells in chronic HIV infection. (2012) (408)
- A Functional Role for Antibodies in Tuberculosis (2016) (387)
- Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells (2004) (383)
- International AIDS Society global scientific strategy: towards an HIV cure 2016 (2016) (372)
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines (2014) (349)
- HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 (2006) (345)
- Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. (2005) (339)
- HIV-1 adaptation to NK cell mediated immune pressure (2011) (337)
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. (2010) (332)
- Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study (2021) (324)
- COVID-19-neutralizing antibodies predict disease severity and survival (2020) (318)
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys (2013) (312)
- Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans (2019) (311)
- Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1 (2011) (310)
- Distinct Early Serological Signatures Track with SARS-CoV-2 Survival (2020) (303)
- Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. (2013) (291)
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology (2015) (286)
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys (2015) (275)
- Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells (2008) (266)
- MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands (2007) (260)
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters (2020) (257)
- COVID-19 neutralizing antibodies predict disease severity and survival (2020) (250)
- Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. (2021) (243)
- Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic (2020) (242)
- CD39 Expression Identifies Terminally Exhausted CD8+ T Cells (2015) (241)
- Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans (2021) (232)
- The Immunoregulatory Roles of Antibody Glycosylation. (2017) (225)
- Ad26/MVA Therapeutic Vaccination with TLR7 Stimulation in SIV-Infected Rhesus Monkeys (2016) (222)
- Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys (2018) (216)
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) (2018) (214)
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. (2021) (211)
- Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses (2020) (211)
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality (2020) (210)
- Sex differences in vaccine-induced humoral immunity (2018) (208)
- Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control (2016) (203)
- Adjuvanting a subunit COVID-19 vaccine to induce protective immunity (2021) (188)
- HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection (2009) (187)
- NK cells in HIV‐1 infection: evidence for their role in the control of HIV‐1 infection (2009) (185)
- Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (2016) (182)
- The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies (2013) (181)
- Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine (2018) (177)
- Dissecting antibody-mediated protection against SARS-CoV-2 (2020) (176)
- High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. (2012) (169)
- Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection (2018) (165)
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production (2020) (165)
- Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 (2016) (165)
- A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. (2018) (162)
- De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection (2005) (161)
- Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. (2007) (159)
- Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (158)
- Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines (2021) (154)
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection (2018) (148)
- Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles (2007) (145)
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (142)
- Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1 (2008) (141)
- Dynamics and significance of the antibody response to SARS-CoV-2 infection (2020) (138)
- COVID-19 vaccine response in pregnant and lactating women: a cohort study (2021) (134)
- Cutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection (2016) (131)
- Compromised SARS-CoV-2-specific placental antibody transfer (2020) (126)
- Loss of CD103+ DCs and Mucosal IL-17+ and IL-22+ Lymphocytes is Associated with Mucosal Damage in SIV Infection (2012) (123)
- Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles (2017) (123)
- Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses (2020) (123)
- HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor–α (2004) (122)
- Increased Natural Killer Cell Activity in Viremic HIV-1 Infection1 (2004) (121)
- Fc Glycan-Mediated Regulation of Placental Antibody Transfer (2019) (119)
- Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. (2021) (117)
- A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation☆ (2019) (112)
- Antibody-mediated protection against Ebola virus (2018) (112)
- Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge (2017) (111)
- A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques (2012) (111)
- Humoral signatures of protective and pathological SARS-CoV-2 infection in children (2021) (110)
- Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells1 (2007) (109)
- Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination (2016) (109)
- Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital (2020) (109)
- Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance. (2011) (109)
- Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). (2013) (109)
- Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV (2018) (108)
- The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial (2018) (106)
- Antibody glycosylation in inflammation, disease and vaccination (2018) (104)
- Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection (2009) (102)
- Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands (2008) (102)
- NK Cells in HIV Disease (2016) (102)
- Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function (2014) (98)
- Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions. (2016) (96)
- A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis (2019) (94)
- Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control (2013) (93)
- Transfer of maternal immunity and programming of the newborn immune system (2017) (91)
- Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. (2006) (91)
- A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. (2015) (89)
- Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses (2015) (89)
- Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b (2013) (88)
- Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19 (2020) (87)
- IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. (2010) (86)
- The Power of Antibody-Based Surveillance (2020) (84)
- Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells. (2012) (83)
- Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies (2016) (79)
- HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. (2004) (77)
- Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. (2011) (75)
- Innate immune control of HIV. (2012) (74)
- Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. (2017) (74)
- Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia (2015) (73)
- Novel KIR3DL1 Alleles and Their Expression Levels on NK Cells: Convergent Evolution of KIR3DL1 Phenotype Variation?12 (2008) (73)
- Discrete SARS-CoV-2 antibody titers track with functional humoral stability (2021) (73)
- Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection. (2019) (72)
- The humoral response to HIV-1: new insights, renewed focus. (2010) (70)
- Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination (2020) (70)
- Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection. (2022) (69)
- Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women (2019) (69)
- NK cell function in HIV-1 infection. (2006) (68)
- SARS-CoV-2-specific ELISA development (2020) (68)
- Early Preservation of CXCR5+ PD-1+ Helper T Cells and B Cell Activation Predict the Breadth of Neutralizing Antibody Responses in Chronic HIV-1 Infection (2014) (68)
- An intranasal vaccine durably protects against SARS-CoV-2 variants in mice (2021) (68)
- A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. (2019) (67)
- Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. (2012) (67)
- Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement (2018) (67)
- Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases (2020) (66)
- Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease (2022) (66)
- Systems serology for evaluation of HIV vaccine trials (2017) (65)
- Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa (2015) (65)
- Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies (2014) (64)
- High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts (2020) (64)
- Modulating Antibody Functionality in Infectious Disease and Vaccination. (2016) (62)
- New paradigms for functional HIV-specific nonneutralizing antibodies. (2013) (61)
- The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. (2021) (61)
- Altered distribution of mucosal NK cells during HIV infection (2011) (60)
- Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization (2020) (60)
- Highly parallel characterization of IgG Fc binding interactions (2014) (60)
- The multifaceted roles of breast milk antibodies (2021) (59)
- Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection12 (2007) (58)
- Defining the risk of SARS-CoV-2 variants on immune protection (2022) (58)
- A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs (2021) (58)
- Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination (2021) (57)
- KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif (2011) (57)
- Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein (2018) (56)
- Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. (2008) (56)
- HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies (2018) (55)
- Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation (2018) (53)
- mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions (2022) (53)
- Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics (2014) (53)
- Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes (2019) (52)
- Multiplexed Affinity-Based Separation of Proteins and Cells Using Inertial Microfluidics (2016) (52)
- Determinants of protection among HIV‐exposed seronegative persons: an overview. (2010) (52)
- Outflanking immunodominance to target subdominant broadly neutralizing epitopes (2018) (51)
- Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16 (2016) (51)
- Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae (2022) (50)
- Systems serology: profiling vaccine induced humoral immunity against HIV (2017) (50)
- Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses (2021) (50)
- Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection 1 (2003) (48)
- A Molecular Signature in Blood Reveals a Role for p53 in Regulating Malaria-Induced Inflammation. (2019) (48)
- Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication. (2015) (47)
- SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung (2021) (47)
- Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus–exposed Uninfected Infants Born in a High-income Country (2018) (47)
- Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2 (2021) (46)
- The Majority of Currently Circulating Human Immunodeficiency Virus Type 1 Clade B Viruses Fail To Prime Cytotoxic T-Lymphocyte Responses against an Otherwise Immunodominant HLA-A2-Restricted Epitope: Implications for Vaccine Design (2005) (46)
- Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine (2019) (46)
- Induction of Gag-Specific CD4 T Cell Responses during Acute HIV Infection Is Associated with Improved Viral Control (2014) (46)
- mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern (2022) (45)
- P10-01. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction (2009) (45)
- Independent evolution of Fc‐ and Fab‐mediated HIV‐1‐specific antiviral antibody activity following acute infection (2014) (45)
- Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection. (2018) (45)
- Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects (2016) (44)
- Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination (2021) (44)
- Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine (2011) (43)
- Divergent Antibody Subclass and Specificity Profiles but Not Protective HLA-B Alleles Are Associated with Variable Antibody Effector Function among HIV-1 Controllers (2013) (42)
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 (2021) (42)
- HIV-1 Single-Stranded RNA Induces CXCL13 Secretion in Human Monocytes via TLR7 Activation and Plasmacytoid Dendritic Cell–Derived Type I IFN (2015) (41)
- Rapid ex vivo isolation and long-term culture of human Th17 cells. (2008) (41)
- Prevention of SHIV transmission by topical IFN-β treatment (2015) (41)
- Omicron variant Spike-specific antibody binding and Fc activity is preserved in recipients of mRNA or inactivated COVID-19 vaccines (2022) (40)
- Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity (2019) (40)
- Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza (2011) (40)
- Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies (2020) (39)
- Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design. (2016) (39)
- KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs. (2014) (39)
- Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. (2020) (38)
- Human Immunodeficiency Virus (HIV)-Specific Gamma Interferon Secretion Directed against All Expressed HIV Genes: Relationship to Rate of CD4 Decline (2005) (38)
- Opportunities to exploit non-neutralizing HIV-specific antibody activity. (2013) (38)
- Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection (2006) (37)
- Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees (2015) (37)
- Decoupling activation and exhaustion of B cells in spontaneous controllers of HIV infection (2013) (36)
- Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination. (2019) (36)
- Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques (2021) (36)
- Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity (2020) (36)
- IgG Binding Characteristics of Rhesus Macaque FcγR (2016) (36)
- Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (2021) (35)
- Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics (2020) (35)
- The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. (2018) (35)
- Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help (2021) (35)
- Immune Correlate-Guided HIV Vaccine Design. (2018) (34)
- Natural killer cells in spontaneous control of HIV infection (2011) (34)
- Early viral replication in lymph nodes provides HIV with a means by which to escape NK‐cell‐mediated control (2011) (34)
- Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas. (2018) (34)
- High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level (2005) (34)
- Consistent Effects of TSG101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 (2006) (33)
- Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors (2017) (33)
- High‐resolution definition of humoral immune response correlates of effective immunity against HIV (2018) (33)
- Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis (2020) (33)
- COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women (2021) (33)
- Ligand-Independent Exhaustion of Killer Immunoglobulin-Like Receptor-Positive CD8+ T Cells in Human Immunodeficiency Virus Type 1 Infection (2008) (32)
- A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis (2019) (32)
- Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination (2021) (32)
- Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates (2021) (32)
- Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. (2002) (31)
- Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge (2018) (31)
- Vi-specific serological correlates of protection for typhoid fever (2020) (31)
- Emergence of Individual HIV-Specific CD8 T Cell Responses during Primary HIV-1 Infection Can Determine Long-Term Disease Outcome (2014) (31)
- CD 39 Expression Identifies Terminally Exhausted CD 8 + T Cells (2015) (31)
- A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasma (2022) (31)
- Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. (2010) (31)
- Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection. (2011) (31)
- Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection (2017) (30)
- Frequent and Strong Antibody-Mediated Natural Killer Cell Activation in Response to HIV-1 Env in Individuals with Chronic HIV-1 Infection (2012) (30)
- Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses (2019) (30)
- Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques (2021) (30)
- Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV (2018) (30)
- Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques (2018) (30)
- First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector (2018) (29)
- KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function (2014) (29)
- Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers (2017) (29)
- Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV (2017) (29)
- Interaction of a dengue virus NS1‐derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells (2015) (28)
- Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. (2021) (28)
- Determining the phagocytic activity of clinical antibody samples. (2011) (28)
- CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception. (2015) (27)
- Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. (2020) (27)
- Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies (2017) (27)
- Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms (2021) (27)
- Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity. (2015) (26)
- Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19 (2020) (26)
- A 17q12 Allele Is Associated with Altered NK Cell Subsets and Function (2012) (25)
- Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors (2021) (25)
- Blimp-1, an Intrinsic Factor that Represses HIV-1 Proviral Transcription in Memory CD4+ T Cells (2015) (25)
- Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study (2020) (25)
- Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults (2013) (25)
- Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients (2020) (25)
- A Sample-Sparing Multiplexed ADCP Assay (2019) (24)
- A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity (2021) (24)
- Correction: Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1 (2011) (24)
- Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2 (2021) (23)
- Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques (2018) (22)
- Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity (2018) (22)
- Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response (2021) (22)
- A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials (2019) (22)
- Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions (2020) (22)
- Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality (2020) (21)
- Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features (2019) (21)
- Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life (2015) (21)
- Mapping the journey to an HIV vaccine. (2013) (20)
- HLA-C levels impact natural killer cell subset distribution and function. (2016) (20)
- COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women (2021) (20)
- Exploiting glycan topography for computational design of Env glycoprotein antigenicity (2018) (20)
- ADCC-Mediated CD56DIM NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection (2018) (19)
- Microscale purification of antigen-specific antibodies. (2015) (19)
- Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site (2018) (19)
- A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. (2020) (19)
- Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques (2021) (19)
- Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy (2020) (19)
- Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates. (2021) (18)
- Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipuncture. (2008) (18)
- High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis (2016) (18)
- Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations (2020) (18)
- Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates (2021) (18)
- Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms (2021) (18)
- Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope (2021) (17)
- CD4+ T cell–dependent and CD4+ T cell–independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals (2015) (17)
- Durability of Heterologous and Homologous COVID-19 Vaccine Boosts (2022) (17)
- Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver (2014) (17)
- Modest Attenuation of HIV-1 Vpu Alleles Derived from Elite Controller Plasma (2015) (16)
- SARS-CoV-2 epitope-specific CD4+ memory T cell responses across COVID-19 disease severity and antibody durability (2022) (16)
- A Drug-Free Zone--Lymph Nodes as a Safe Haven for HIV. (2016) (16)
- Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22). (2020) (16)
- Unique repertoire of anti-carbohydrate antibodies in individual human serum (2020) (15)
- HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound. (2020) (15)
- Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa. (2013) (15)
- Multi-isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific N-Glycosylation Profiles. (2019) (15)
- Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir. (2019) (15)
- Mining for humoral correlates of HIV control and latent reservoir size (2020) (15)
- HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection (2020) (14)
- Multi-isotype Glycoproteomic Characterization of Serum Antibody Heavy Chains Reveals Isotype- and Subclass-Specific N-Glycosylation Profiles* (2019) (14)
- ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type (2019) (14)
- Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection (2019) (14)
- Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate (2018) (14)
- Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap (2018) (14)
- An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa (2020) (13)
- Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles (2021) (13)
- Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations (2020) (13)
- Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques (2020) (13)
- Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects (2021) (13)
- Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus (2021) (13)
- Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19 (2021) (13)
- Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection (2021) (12)
- Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress (2021) (12)
- Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination (2021) (12)
- Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis (2023) (12)
- Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys (2018) (12)
- Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination (2016) (12)
- Neonate-omics: Charting the Unknown Immune Response in Early Life (2018) (11)
- Antibody Subclass and Glycosylation Shift Following Effective TB Treatment (2021) (11)
- Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection (2004) (11)
- Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response (2020) (11)
- Tissues: the unexplored frontier of antibody mediated immunity. (2021) (11)
- Sexually dimorphic placental responses to maternal SARS-CoV-2 infection (2021) (11)
- Epidemiological and immunological features of obesity and SARS-CoV-2 (2020) (11)
- Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study (2022) (11)
- KIR/HLA: genetic clues for a role of NK cells in the control of HIV. (2011) (10)
- Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth (2020) (10)
- Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19 (2020) (10)
- Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine (2018) (10)
- IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees (2020) (9)
- In situ production of therapeutic monoclonal antibodies (2015) (9)
- Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques (2021) (9)
- A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques (2022) (9)
- Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs (2018) (9)
- Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ (2020) (9)
- Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection (2022) (9)
- T cell and antibody functional correlates of severe COVID-19 (2020) (9)
- The Antibodiome—Mapping the Humoral Immune Response to HIV (2019) (9)
- Comprehensive antibody profiling of mRNA vaccination in children (2021) (8)
- A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 delta infection (2022) (8)
- Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children (2021) (8)
- Expansion of Stem Cell-Like CD4+ Memory T Cells during Acute HIV-1 Infection Is Linked to Rapid Disease Progression (2019) (8)
- Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 (2020) (8)
- Dissecting the antibody constant region protective immune parameters in HIV infection (2014) (8)
- Effect of Human Immunodeficiency Virus Infection on Plasma Bactericidal Activity against Salmonella enterica Serovar Typhimurium (2014) (8)
- Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates (2022) (8)
- Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies (2013) (8)
- COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women (2022) (8)
- RV144 HIV-1 vaccination impacts post-infection antibody responses (2020) (8)
- Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection (2007) (8)
- Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation. (2018) (8)
- Enrichment of high affinity subclasses and glycoforms from serum‐derived IgG using FcγRs as affinity ligands (2018) (7)
- Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans (2018) (7)
- The HIV-1 Glycan Shield: Strategically Placed Kinks in the Armor Improve Antigen Design. (2017) (7)
- Dissecting the antibody-OME: past, present, and future. (2020) (7)
- Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity (2022) (7)
- Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. (2021) (7)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
- Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features (2021) (7)
- Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma (2020) (7)
- SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort (2022) (7)
- Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response (2022) (7)
- Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 (2021) (7)
- Antibodies for Human Immunodeficiency Virus-1 Cure Strategies. (2021) (6)
- Natural Evolution of Broadly Neutralizing Antibodies (2015) (6)
- Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response. (2020) (6)
- Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients (2022) (6)
- Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection (2020) (6)
- Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program (2021) (6)
- mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes (2022) (6)
- Functional Antibodies in COVID-19 Convalescent Plasma (2021) (6)
- Machine Learning Methods Enable Predictive Modeling of Antibody Feature : Function Relationships in RV 144 Vaccinees (2015) (5)
- Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells (2021) (5)
- Early Preservation of CXCR 5 PD-1 Helper T Cells and B Cell Activation Predict the Breadth of Neutralizing Antibody Responses in Chronic HIV-1 Infection (2014) (5)
- Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19 (2022) (5)
- Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis (2022) (5)
- Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials (2021) (5)
- Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children (2022) (5)
- Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients (2021) (5)
- SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children (2022) (5)
- The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia (2022) (5)
- Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features (2021) (5)
- Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV (2022) (5)
- AIDS Vaccine 2008 Conference (2009) (5)
- Serological Markers of SARS-CoV-2 Reinfection (2022) (5)
- Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals (2021) (5)
- Perspective natural killer cells: bridging innate and adaptive immunity? (2006) (4)
- Opportunities to exploit antibody glycosylation in vaccination (2017) (4)
- Broadly Neutralizing Antibodies: Magic Bullets against HIV? (2016) (4)
- Development of a Human Antibody Cocktail that DeploysMultiple Functions toConfer Pan-Ebolavirus Protection Graphical (2019) (4)
- Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma (2021) (4)
- Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection (2020) (4)
- Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (4)
- Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-alpha inhibitors (2021) (4)
- Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors (2021) (4)
- Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine (2022) (4)
- Production of HIV-1 Env-Specific Antibodies Mediating Innate Immune Functions Depends on Cognate Interleukin-21- Secreting CD4+ T Cells (2021) (4)
- Functional and structural modifications of influenza antibodies during pregnancy (2021) (3)
- Prediction of VRC 01 neutralization sensitivity by HIV-1 gp 160 sequence features (3)
- Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection (2022) (3)
- Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial (2022) (3)
- Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. (2020) (3)
- 338: Maternal Tdap: how do antibodies protect newborns against pertussis? (2017) (3)
- Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. (2012) (3)
- NIAID workshop on secondary vaccine effects (2021) (3)
- Antibody effector functions are associated with protection from respiratory syncytial virus (2022) (3)
- A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis (2021) (3)
- Simultaneous detection of SARS-CoV-2 RNA and host antibodies enabled by a multiplexed electrochemical sensor platform (2021) (3)
- Young and Early Career Investigators: Report from a Global HIV Vaccine Enterprise Working Group (2010) (3)
- Epidemiological and Immunological Features of Obesity and SARS-CoV-2 (2021) (3)
- Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies (2022) (3)
- A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection (2022) (3)
- Adoptive Transfer of Serum Samples From Children With Invasive Staphylococcal Infection and Protection Against Staphylococcus aureus Sepsis. (2020) (3)
- Durability of anti-Spike antibodies in the infant after maternal COVID-19 vaccination (2021) (3)
- Evolution of functional antibodies following acute Epstein-Barr virus infection (2022) (3)
- Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses (2022) (3)
- Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated Mothers (2022) (2)
- What mAbs tell us about shapes: multiple roads lead to Rome. (2013) (2)
- Integrated technology platform for accelerated discovery of antiviral antibody therapeutics (2020) (2)
- Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community (2022) (2)
- HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression (2021) (2)
- Antibody against envelope protein from human endogenous retrovirus activates neutrophils in systemic lupus erythematosus (2019) (2)
- A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challenge (2022) (2)
- Systems approach to define humoral correlates of immunity to Shigella (2022) (2)
- BA.2 evasion of vaccine induced binding and functional non-neutralizing antibodies (2022) (2)
- Altered maternal antibody profiles in women with HIV drive changes in transplacental antibody transfer. (2022) (2)
- Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012. (2013) (2)
- Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection (2020) (2)
- COVID-19 Vaccine Responsiveness in Patients with Multiple Myeloma and Waldenström Macroglobulinemia (2021) (2)
- Robust IgM responses following vaccination are associated with prevention of Mycobacterium tuberculosis infection in macaques (2021) (2)
- Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children (2022) (2)
- A multifaceted high-throughput assay for probing antigen-specific antibody-mediated primary monocyte phagocytosis and downstream functions. (2022) (2)
- Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
- SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome (2022) (2)
- Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (2)
- A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques (2022) (2)
- Preserved recognition of Omicron Spike following COVID-19 mRNA vaccination in pregnancy (2022) (2)
- Control of Heterologous SIVsmE660 infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques (2018) (2)
- Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunity. (2018) (2)
- Selective transfer of maternal antibodies in preterm and fullterm children (2022) (2)
- Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors (2022) (2)
- Innovative vaccine approaches—a Keystone Symposia report (2022) (2)
- Measles Vaccination Elicits a Polyfunctional Antibody Response, Which Decays More Rapidly in Early Vaccinated Children (2021) (2)
- Maternal determinants of infant immunity: Implications for effective immunization and maternal-child health. (2020) (2)
- Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination (2022) (2)
- Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination (2021) (2)
- SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection (2023) (2)
- Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2 (2022) (2)
- BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children (2022) (1)
- Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022 (2020) (1)
- Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys (2018) (1)
- The persistence of memory: defining, engineering, and measuring vaccine durability (2022) (1)
- Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses (2021) (1)
- Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens (2021) (1)
- Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy (2022) (1)
- Adapting Disease Prevention Protocols for Human Spaceflight During COVID-19. (2021) (1)
- mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in patients with antibody deficiency syndromes (2022) (1)
- SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies (2023) (1)
- Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection (2012) (1)
- Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center (2022) (1)
- Consistent Effects of TSG 101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 † (2018) (1)
- Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials (2021) (1)
- Natural Killer cells present in gut mucosa as potential ADCC effector cells (2012) (1)
- The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design (2022) (1)
- Humoral signatures of MOG-antibody-associated disease track with age and disease activity (2023) (1)
- Fc-engineered antibodies leverage neutrophils to drive control of Mycobacterium tuberculosis (2022) (1)
- Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPSTM) SARS-CoV-2 Vaccine (2022) (1)
- SARS-CoV-2 infection and reinfection in a seroepidemiological workplace cohort in the United States (2021) (1)
- Distinct HIV-Specific Antibody Fc-Profiles in RV144 and VAX003 Vaccinees (2013) (1)
- Systems serology: profiling vaccine induced humoral immunity against HIV (2017) (1)
- KIR2DL3+ NKG2A- Natural Killer Cells Protect People who Inject Drugs against Productive Hepatitis C Virus Infection (2014) (1)
- Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy (2022) (1)
- A Case-Control study identifying highly tuberculosis-exposed, HIV-1-infected but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa (2020) (1)
- PLOS Medicine 2015 Reviewer Thank You (2016) (1)
- This information is current as Viral Infection Expression Is Required To Control Chronic Intrinsic T-bet − Cutting Edge : B Cell (2016) (1)
- Vector induced skewing of antibody Fc-effector functions (2012) (1)
- A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy (2022) (1)
- Differential SARS-CoV-2 Antibody Profiles after Allergic Reactions to mRNA COVID-19 Vaccine. (2022) (1)
- Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses (2022) (1)
- Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression (2012) (1)
- IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern (2022) (1)
- Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children (2022) (1)
- PLOS Pathogens 2014 Reviewer Thank You (2015) (1)
- Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques (2021) (1)
- Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV (2018) (1)
- Selective transfer of maternal antibodies in preterm and fullterm children (2021) (1)
- Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges (2022) (1)
- Corrigendum to “A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples” (2012) (0)
- Natural Killer cells present in gut mucosa as potential ADCC effector cells (2012) (0)
- P16-18. Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection (2009) (0)
- Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (0)
- 124 NK cells: friends or foes? (2009) (0)
- Antibody glycosylation: an emerging biomarker of disease activity/protection (2017) (0)
- UMOYA: a prospective longitudinal cohort study to evaluate novel diagnostic tools and to assess long-term impact on lung health in South African children with presumptive pulmonary TB—a study protocol (2023) (0)
- The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection (2022) (0)
- NON-NEUTRALIZING ANTIBODIES FROM A MARBURG INFECTION SURVIVOR MEDIATE PROTECTION BY INDUCTION OF STRONG FC-EFFECTOR FUNCTIONS AND ENHANCEMENT OF NEUTRALIZING EFFECTS OF OTHER ANTIBODIES, Philipp Ilinykh et al (2020) (0)
- Human antibody cocktail deploys multiple functions to confer pan-ebolavirus protection (2018) (0)
- Waning and boosting of functional humoral immunity to SARS-CoV-2 (2022) (0)
- Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type (2019) (0)
- A systems serology analysis of correlates of protection against cholera (2022) (0)
- P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication (2009) (0)
- Antiretroviral Therapy in Primary Infection HIV-Infected Patients Starting Highly Active HIV-Specific Effector Activity in Longitudinal Assessment of Changes in Sékaly (2003) (0)
- Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection (2023) (0)
- A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection (2022) (0)
- CD4 + T cell–dependent and –independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals (2015) (0)
- COVID-19 booster dose antibody response in pregnant, lactating, and nonpregnant women (2022) (0)
- Impact of Maternal Vaccination on Antibody Transfer and Protection of Infants (2021) (0)
- Challenges facing young investigators. (2009) (0)
- Role of innate immunity in the control of HIV infection (2010) (0)
- Accumulation of neutrophil-phagocytic antibody features tracks with naturally acquired immunity against malaria in children (2023) (0)
- P10-11. NK cells do not accumulate at sites of HIV-replication but show increased activation (2009) (0)
- Transfection of dendritic cells (DCs) with mRNA encoding IL-12p70 enhances anti-tumor immunity in melanoma patients (2008) (0)
- CD39 is highly up-regulated by exhausted CD8 + T cells in a mouse model of chronic infection. (2015) (0)
- Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination (2012) (0)
- OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia (2021) (0)
- An antibody tag-team: driving neutralization through escape. (2014) (0)
- Antibody effector function is regulated by a combination of adaptive and innate signals (2012) (0)
- Deconvolution of Glycan Occupancy Heterogeneity for Rational HIV Immunogen Design (2017) (0)
- Author index (1985) (0)
- Reply to Slogrove et al. (2018) (0)
- Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination (2023) (0)
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters (2020) (0)
- Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design (2023) (0)
- Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination (2012) (0)
- Antibody-mediated protection against Ebola virus (2018) (0)
- Vector induced skewing of antibody Fc-effector functions (2012) (0)
- Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection (2012) (0)
- Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection (2018) (0)
- Ligand-Independent Exhaustion of Killer Immunoglobulin-Like Receptor-Positive CD8 (cid:1) T Cells in Human Immunodeficiency Virus Type 1 Infection (cid:1) (2008) (0)
- Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines (2022) (0)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (0)
- Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study. (2022) (0)
- Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression (2012) (0)
- Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine (2022) (0)
- T cell and antibody functional correlates of severe COVID-19 3 4 (2020) (0)
- Upper and Lower Respiratory Tract Correlates of Protection Against RSV Following Vaccination of Non-Human Primates (2021) (0)
- Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19 (2023) (0)
- Effect of Human Immunodeficiency Virus Infection on Plasma Bactericidal Activity against Salmonella enterica Serovar Typhimurium (2014) (0)
- Author index (1994) (0)
- Serum And Cerebrospinal Fluid Antibody Signatures Track With Outcome Of Neurologic Post-Acute Sequelae Of SARS-Cov-2 Infection (NeuroPASC) (S21.006) (2023) (0)
- Humoral immune responses against SARS-CoV-2 in transplantation: Actionable biomarker or misplaced trust? (2022) (0)
- Antibody effector function is regulated by a combination of adaptive and innate signals (2012) (0)
- CD39 expressed by CD8 + T cells in HCV infection is enzymatically active. (2015) (0)
- Resilient Fc-Effector Functions Across SARS-CoV-2 Variants of Concern Following mRNA-1273 Vaccination (2021) (0)
- Correction: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (2016) (0)
- Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability (2022) (0)
- Immune Responses to Viral Infection (2017) (0)
- Viremic HIV-1 Infection Increased Natural Killer Cell Activity in Zaunders and Marcus (2004) (0)
- NK Cells in HIV Disease The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2016) (0)
- Anamnestic Humoral Correlates of Immunity Across SARS-CoV-2 Variants of Concern (2022) (0)
- Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 counts (2022) (0)
- Multivariate Analysis Establishes Airway T Cells as a Correlate of IV BCG-Mediated Protection Against Tuberculosis in Rhesus Macaques (2022) (0)
- Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination (2023) (0)
- Dissecting antibody-mediated protection against SARS-CoV-2 (2020) (0)
- The PhenoGenetic Project: A Living Biobank Enabling the Study of Human Genetic and Immunologic Variation (2010) (0)
- Two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates (2018) (0)
- Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 (2023) (0)
- Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination (2023) (0)
- Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens (2022) (0)
- Reply (2020) (0)
- Antibody Transfer via Breastmilk After SARS-CoV-2 Infection (2021) (0)
- IgG is differentially and selectively transferred across the placenta in HIV-infected women (2018) (0)
- Expression directe d'anticorps (2015) (0)
- 1 Monoclonal Antibody b 12 Has Enhanced Fc ? RIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques Permalink (2012) (0)
- Coronavirus Immunotherapeutic Consortium Database (2023) (0)
- Therapeutic human monoclonal antibody MR191 bound to a marburgvirus glycoprotein (2018) (0)
- P10-03. Dramatic changes in Fc-receptor expression during HIV-1 infection associated with reduced phagocytic activity during progressive HIV-1 infection (2009) (0)
- Derived Type I IFN - CellTLR7 Activation and Plasmacytoid Dendritic CXCL13 Secretion in Human Monocytes via HIV-1 Single-Stranded RNA Induces (2015) (0)
- Reply (2020) (0)
- Terminally exhausted CD8+ T cells marked by high levels of CD39 are most impaired in their effector function. (2015) (0)
- G-105 Defining protective antibody profiles against HIV utilizing systems serology (2016) (0)
- Progress in vaccine development for infectious diseases-a Keystone Symposia report. (2023) (0)
- Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features (2021) (0)
- Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system (2023) (0)
- Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics (2020) (0)
- MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands (cid:1) (2007) (0)
- Structural and functional analysis of cooperativity in a potent human antibody cocktail against Ebola virus (2020) (0)
- Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV (2023) (0)
- Neurologic sequalae of COVID-19 are determined by immunologic imprinting from previous Coronaviruses. (2022) (0)
- INERTIAL MICROFLUIDICS FOR MULTIPLEXED AFFINITY SEPARATION OF PROTEINS AND CELLS (2014) (0)
- Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses. (2023) (0)
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (0)
- CD39 expression correlates with PD-1 expression and viral load in chronic viral infection. (2015) (0)
- Delayed Booster Dosing Modulates Human Antigen-Specific Ig and B Cell Responses to the RH5.1/AS01 B Malaria Vaccine (2022) (0)
- Transfer of maternal immunity and programming of the newborn immune system (2017) (0)
- Kinetics of gp41-specific antibody titers and contribution of Fc mediated gp41 specific antibody responses following SHIV-SF162P3 challenge. (2014) (0)
- Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions (2023) (0)
- Functional evidence supporting the predicted role of KIR3DS1 in the host response to HIV: KIR3DS1 is an activating receptor expressed by human Natural Killer cells (52.5) (2007) (0)
- Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. (2023) (0)
- CD 4 + T cell – dependent and – independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals (2015) (0)
- The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial (2018) (0)
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques (2020) (0)
- CWRU CFAR 2012 Annual Conference: AIDS Pathogenesis, Prevention and Cure (2012) (0)
- Influenza and pertussis transplacental antibody transfer in women with and without preeclampsia (2020) (0)
- Defining the phenotype and transcriptome of IgG3+ B cells (2016) (0)
- Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys (2018) (0)
- Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study. (2023) (0)
- Persistent Maintenance of Atypical Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response (2022) (0)
- HIV PATHOGENESIS AND TREATMENT ( AL LANDAY , SECTION EDITOR ) NK Cells in HIV Disease (2016) (0)
- current as T Cells + CD 4 HIV-1 Proviral Transcription in Memory Blimp-1 , an Intrinsic Factor that Represses (2015) (0)
- Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination (2023) (0)
- Diagnostic TR-FRET assays for detection of antibodies in patient samples (2023) (0)
- Sex differences in vaccine-induced humoral immunity (2018) (0)
- Reply to Alaedini and Wormser. (2022) (0)
This paper list is powered by the following services:
Other Resources About Galit Alter
What Schools Are Affiliated With Galit Alter?
Galit Alter is affiliated with the following schools:
